Chapter title |
Genetic Instability and Disease Prognostication.
|
---|---|
Chapter number | 4 |
Book title |
Chromosomal Instability in Cancer Cells
|
Published in |
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2015
|
DOI | 10.1007/978-3-319-20291-4_4 |
Pubmed ID | |
Book ISBNs |
978-3-31-920290-7, 978-3-31-920291-4
|
Authors |
Gemoll, Timo, Auer, Gert, Ried, Thomas, Habermann, Jens K, Timo Gemoll, Gert Auer, Thomas Ried, Jens K. Habermann, Habermann, Jens K. |
Abstract |
Genetic instability is a striking feature of human cancers, with an impact on the genesis, progression and prognosis. The clinical importance of genomic instability and aneuploidy is underscored by its association with poor patient outcome in multiple cancer types, including breast and colon cancer. Interestingly, there is growing evidence that prognostic gene expression signatures simply reflect the degree of genomic instability. Additionally, also the proteome is affected by aneuploidy and has therefore become a powerful tool to screen for new targets for therapy, diagnosis and prognostication. In this context, the chapter presents the impact of genomic instability on disease prognostication occurring in human cancers. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 13 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 2 | 15% |
Student > Bachelor | 2 | 15% |
Student > Ph. D. Student | 2 | 15% |
Researcher | 2 | 15% |
Student > Master | 2 | 15% |
Other | 3 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 46% |
Unspecified | 2 | 15% |
Agricultural and Biological Sciences | 2 | 15% |
Medicine and Dentistry | 2 | 15% |
Unknown | 1 | 8% |